Revance Therapeutics shares owned by Silverback Asset Management
Quarter-by-quarter ownership of Revance Therapeutics shares owned by Silverback Asset Management
from 13F filings
Historical chart of Silverback Asset Management investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by Silverback Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Revance Therapeutics by Silverback Asset Management
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $11M | 15M | 0.74 |
2023-09-30 | $4.0B | 5.0M | 806.88 |
More positions owned by Silverback Asset Management
View all positions for Silverback Asset Management